Inhibition of progesterone (P4) synthesis by cumulus cells during bovine in vitro oocyte maturation (IVM) causes a decrease in subsequent embryo development, indicating that P4 intracellular signaling within the cumulus oocyte complex (COC) is important for oocyte developmental competence. The aim of the present study was to further elucidate, on a protein level, the downstream signaling pathway involved in P4 regulation of oocyte developmental competence. COCs were subjected to IVM for 24 h in the presence or absence of trilostane, aglepristone, or promegestone (R5020). These altered IVM conditions resulted in dynamic changes in protein expression of the progesterone receptors and the cell deathregulated proteins AVEN, BCL-xL, and active caspase 3. In addition, AVEN protein localization, caspase 3 activation, and mitochondrial distribution were studied by immunofluorescence. Inhibition of progesterone synthesis (trilostane treatment) resulted in changes in AVEN localization within the COC, corresponding to caspase 3 activation and altered mitochondrial distribution. AVEN was also found to bind BCL-xL in COCs, but this interaction was lost following treatment with trilostane.
INTRODUCTION
Although progesterone (P4) signaling through P4 receptors (PRs) is known to trigger oocyte maturation in fish and frogs, its role in regulating oocyte maturation and subsequent embryonic survival in mammalian species is less well defined [1] [2] [3] . Nevertheless, there is a body of data from species such as pig and mouse which suggests that P4 promotes oocyte maturation in vitro [4] [5] [6] . In addition, P4 has been shown to play an important role in regulating bovine oocyte maturation both in vivo and in vitro; inhibition of P4 synthesis and blockage of the PRs have negative effects on oocyte maturation and/or subsequent embryonic development [7] [8] [9] . In bovine, P4 appears to exert its effect on oocyte competence by signaling through both nuclear (PGRs) and membrane P4 receptors (mPR) [7, 9] .
Several studies have indicated a prosurvival or antiapoptotic role for P4 in female reproductive tissues; for example, P4 has been shown to inhibit apoptosis in the uterus [10] , corpus luteum [11, 12] , and ovarian follicle [13] . Whereas treatment of spontaneous immortalized rat granulosa cells with P4 was shown to induce the antiapoptotic gene Bcl2a1d and suppress the proapoptotic gene Bad, the expression of these genes was regulated by PGRMC1 [14] . Similarly, P4 increased antiapoptotic Bcl-2 and Bcl-xL mRNA and protein levels in rat models of traumatic brain injury [15] .
We recently identified AVEN, a novel P4-regulated protein [16] , as a putative biomarker of oocyte quality [17] . AVEN is known to play a role in male and female germ cell development; downregulation of AVEN was associated with incomplete spermatogenesis in mice [18] and Vasa-homologdeficient mice, which display abnormal spermatogenesis and fail to express AVEN [19] , whereas overexpression of human AVEN mRNA in Xenopus laevis oocytes delays P4-induced meiotic maturation [20] . AVEN protein has also been shown to inhibit the mitochondrial apoptosis pathway by binding to and inhibiting the self-association of proapoptotic APAF-1 [21, 22] , as well as binding to and enhancing antiapoptotic BCL-xL activity [21, [23] [24] [25] . However, AVEN can induce apoptosis in cells with high levels of DNA damage while promoting the recovery of cells with lower levels of DNA damage. Taking these points into consideration, we hypothesized that P4 synthesis by cumulus oocyte complexes (COCs) during meiotic maturation plays an important role in protecting oocytes from apoptosis and that this action is mediated by AVEN, which monitors cell integrity/quality and induces apoptosis in oocytes and embryos with DNA damage and/or chromosomal abnormalities. The aim of the current study was to test these hypotheses.
MATERIALS AND METHODS

P4 Production During In Vitro Maturation
In order to measure P4 production during in vitro maturation (IVM), samples of medium were collected after 24-h culture in maturation medium in the absence or presence of trilostane, aglepristone, and/or R5020. P4 concentrations were determined using the solid phase radioimmunoassay Coat-A-Count progesterone kit (Siemens Medical Solutions Diagnostics) as previously described [7] .
AVEN Sequence Analysis
Multiple protein sequence alignment of bovine (accession no. XP_002700612), human (accession no. NP_065104), X. laevis (accession no. NP_001090621), and Xenopus tropicalis (accession no. XP_002935375) AVEN sequences (http://www.ncbi.nlm.nih.gov/protein/) was performed using ClustalW software (http://www.clustal.org) and analyzed using the Jalview graphical interface (www.jalview.org/). Potential phosphorylation sites were predicted using PhosphoSite software (http://www.phosphosite.org).
Bovine COC Collection and In Vitro Maturation
Unless stated otherwise, all reagents were purchased from Sigma-Aldrich. Immature COCs were obtained by aspirating surface visible follicles (3-8 mm) from the ovaries of cattle slaughtered at a local abattoir. Good quality COCs were selected, washed, and placed in groups of up to 50 COCs in 500-ll maturation medium (tissue culture medium-199 supplemented with 10% [v/v] fetal calf serum and 10 ng/ml epidermal growth factor) in a 4-well dish and cultured at 398C for 24 h in a humidified atmosphere containing 5% CO 2 . To study the role and signaling mechanism of P4, during oocyte meiotic maturation, IVM was performed in (i) maturation medium as described above (COC control); (ii) maturation medium supplemented with 1 lM trilostane [7] , an inhibitor of 3 b-hydroxysteroid dehydrogenase (COC-P4; Stegram Pharmaceuticals Ltd.); (iii) maturation medium supplemented with 1 lM trilostane and 50 or 100 ng/ml promegestone (R5020; nonmetabolizable P4 agonist; COC-P4/þR5020) [7] ; or (iv) maturation medium supplemented with 1 lM aglepristone (COC-PGR; which blocks PGR-mediated effects of P4 irrespective of its origin [26] ; RU534; Alizine; C&M Vetlink]). Aglepristone has a relative binding affinity equal to that of RU486 for the progesterone receptor (.9 times greater than that of progesterone), with negligible affinity for the glucocorticoid receptor (technical profile; C&M Vetlink). Samples were collected at 0, 6, 12, and 24 h after onset of IVM.
Protein Analysis
Western blotting. Five replicate pools of 70 COCs were removed from IVM at 0, 6, 12, or 24 h, and oocytes were denuded of their cumulus cells by gentle pipetting and repeated washing in PBS. Cumulus cells were recovered for analysis by centrifugation at 3000 3 g for 3 min. Oocyte and cumulus samples were separately resuspended in lysis buffer (M-PER mammalian protein extraction reagent; Pierce) supplemented with protease and phosphatase inhibitors (Roche), and frozen and thawed 3 times. Whole oocyte samples were loaded on gels for Western blotting (70 oocytes/lane containing 15 mg of protein in a 2-ll volume). Cumulus cell samples were then centrifuged for 15 min at 10 000 3 g at 48C, and the supernatant was collected for analysis. Fifteen milligrams of cumulus cell protein per lane was loaded. Protein concentrations were determined using the Bradford assay [27] . To separate proteins according to their apparent molecular mass, SDS-PAGE and immunoblotting were performed as previously described [7] . Immunoblotting was performed by incubating the membranes in BSA blocking buffer with primary antibodies listed below (Table 1) . Anti-GAPDH antibody was used as a loading control due to being a constitutively expressed housekeeping protein [28, 29] . Membranes were subsequently washed in phosphate-buffered saline containing 0.1% Tween (PBST) and incubated with goat anti-rabbit horseradish peroxidase-conjugated secondary antibody (Jackson Laboratories) for 30 min at room temperature. Following washing with PBST, the signal was visualized using ECL Western blotting substrate (product no. 32106; Pierce) according to the manufacturer's instructions.
Whole-Mount Immunofluorescence
CaspGLOW and MitoTracker. Active caspase 3 was stained using the CaspGLOW fluorescein active caspase 3 staining kit (product no. 88-7004; eBioscience), according to the manufacturer's instructions. The fluorescein isothiocyanate (FITC)-DE-VD-FMK component was diluted (1:300) in PBS containing 3% BSA. COCs were incubated in this solution for 60 min at 398C in 5% CO 2 , following which, COCs were incubated for 30 min in PBS containing 3% BSA and 200 nM MitoTracker orange CMTM Ros (Molecular Probes) at 398C in 5% CO 2 . A portion of the oocytes was denuded of cumulus investments by repeated pipetting. Whole COCs and denuded oocytes were fixed in 4% paraformaldehyde for 1 h at 48C, followed by a 15-min wash in PBS plus 3% BSA. The fixed samples were subsequently stored in PBS plus 3% BSA at 48C, for up to 1 week.
AVEN. The samples processed as above were put through a sequence of washes in PBS containing 1% Triton X-100 (PBSTx) and were then blocked for 2 h at room temperature in PBSTx containing 5% goat serum to avoid nonspecific binding of the antibodies. The COCs were subsequently incubated with AVEN primary antibody at a concentration of 1/200 overnight at 48C; a matched rabbit IgG antibody was used as a negative control. Following repeated washing in PBSTx and a 1-h wash in PBS containing 3% BSA, samples were incubated with the secondary antibody (Alexa Fluor 647 goat anti-rabbit, 1:1000) for 4 h at 48C. Excess labeling was removed by repeated washing in PBSTx, and oocytes/COCs were mounted on glass slides, immersed in mounting medium containing 1 lg/ml 4 0 ,6-diamidino-2-phenylindole (DAPI) and covered with a glass cover slip. Three replicates of 40 oocytes per group were analyzed; a replicate refers to 1 day of oocyte collection and IVM.
Image acquisition and analysis. Immunolabeled oocytes were analyzed using the FLUOVIEW FV1000 model (Olympus) confocal laser scanning microscope equipped with an 340/numerical aperture 1.15 water immersion objective and an 360/1.35 numerical aperture oil immersion objective with zoom function. The fluorochrome was excited using the appropriate combination of excitation and barrier filters and laser lines for DAPI (405 nm), FITC (488 nm), Mitotracker orange (559 nm), and Alexa Fluor 647 (635 nm). The settings were kept constant during acquisition of images from all samples. A normal rabbit IgG antibody was used as the negative control to establish a pixel intensity that eliminated 99% of the background signal. Background fluorescence was then subtracted by applying this threshold to all images.
MitoTracker-treated oocytes were divided into 7 serial optical sections (z series), the equatorial plane (frame 4) was used for subsequent quantitative analysis.
Following image acquisition, fluorescence intensity per unit area was determined for MitoTracker-and CaspGLOW-treated oocytes by using ImageJ software (http://rsbweb.nih.gov/ij/) [30] .
Co-immunoprecipitation
Endogenous protein was immunoprecipitated by incubating 100 bovine oocytes with AVEN mAb or corresponding mg/ml matched rabbit IgG antibody (product no. 2729; CellSignaling) overnight at 48C on a bottom-overtop rotator. The antibody-antigen complex was pulled down using A/G agarose bead slurry (Pierce) according to the manufacturer's instructions. NuPAGE SDS loading buffer was added to the final antibody-antigen bead complex and boiled for 5 minutes at 958C and centrifuged, and the supernatant was recovered for Western blotting.
Statistical Analysis
Densitometry data from the Western blots were analyzed using ANOVA followed by Scheffe t-test. All statistical analyses were carried out using Prism 6 software (GraphPad). Differences between groups were considered significant when P values were less than 0.05.
RESULTS
AVEN Sequence Analysis
Analysis of the AVEN protein sequence showed high conservation among bovine, human, and Xenopus species (Fig.  1) . Several known regulatory domains were found to be O'SHEA ET AL.
FIG. 1. Sequence alignment of the AVEN proteins in human (accession no. NP_065104), bovine (XP_002700612), X. tropicalis (accession no. XP_002935375), and X. laevis (accession no. NP_001090621). This multiple alignment was performed using ClustalW and analyzed using the Jalview graphical interface. Consensus is indicated below the alignment. Potential and known phosphomotifs and binding and cleavage sites are indicated. LR-NES, leucine-rich nuclear export sequence.
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conserved in the bovine sequence, including the Bcl-xL binding domain [21] , the cathepsin D cleavage site [31] and caspase 8/9 cleave domain [32] . The AVEN protein sequence was also found to contain several conserved putative phosphomotifs, including a casein kinase 2 (CK2) motif, an ataxia telangiectasia-mutated (ATM) motif, and a protein kinase A (PKA) motif.
Effects of Inhibition of P4 Production and PGR Inhibition on Oocyte Nuclear Maturation
Treatment of COCs during IVM with 10 lM trilostane (COC-P4) produced a significant decrease in P4 concentration measured in the medium (0.31 6 0.05 ng/ml) compared with that of the control (41.34 6 4.25 ng/ml), corresponding to previously reported results [7] . Treatment of COCs with either trilostane or aglepristone during IVM had no effect on the rate of oocyte nuclear maturation, as assessed by nuclear staining at 6-h intervals, with an n value .100 per time point (Table 2) .
Effect of Inhibition of P4 Production on Candidate Protein Expression in COCs During IVM
Western blot analysis confirmed the expression of pMAPK, a marker of germinal vesicle breakdown, in bovine oocytes following IVM. pMAPK expression was lower in COC-P4 oocytes than in COC control oocytes ( Fig. 2A) .
For P4 receptors, the expression levels of PGR-A, mPRa (PAQR7), and mPRb (PAQR8) decreased during IVM in COC control oocytes. In contrast, their expression levels did not change in COC-P4 oocytes. PGR-B was not detected in oocytes, regardless of treatment ( Fig. 2A) . The expression of PGRs (PGR-A, PGR-B) and mPRs (mPRa and mPRb) increased in COC control cumulus cells, but there was no change in their expression levels in COC-P4 (Fig. 2B) .
Expression of AVEN was lowest at 24 h post-IVM (24h) in COC control oocytes. In contrast, AVEN expression peaked at 24 h in COC-P4 oocytes (T24h) (Fig. 2A) . Cumulus cell AVEN protein expression mirrored that of the oocytes; it was lowest in the 24-h COC control cumulus cells and highest in the T24h COC-P4 cumulus cells (Fig. 2B) .
For BCL-xL and active caspase 3, the expression of antiapoptotic BCL-xL, which is known to bind to AVEN, was consistently expressed during IVM in COC control oocytes, and active caspase 3, the apoptosis marker, was not detected at any time point. However, BCL-xL expression was decreased, and active caspase 3 expression was detected from 12-h post-IVM (T12h) onward in COC-P4 oocytes (Fig. 2A) . The temporal profiles of cumulus cell expression levels of BCL-xL and active caspase 3 mirrored those of the oocytes in COC control and COC-P4 cumulus cells (Fig. 2B) .
Effect of PGR Inhibition on Candidate Protein Expression in COCs during IVM
The expression levels of AVEN, BCL-xL, PGR-A, PGR-B, and active caspase 3 in COC-PGR oocytes and cumulus cells followed the same expression pattern observed in COC-P4 oocytes (Fig. 2, A and B) . However, unlike that observed in COC-P4 oocytes, there was no differences in the expression profiles of pMAPK, and the expression of mPRa and mPRb was downregulated in COC-PGR oocytes compared to that of COC control oocytes (Fig. 3A) . The mPRs mPRa and mPRb, which were upregulated in the cumulus cells from control maturation oocytes, were also upregulated in COC-PGR cumulus cells (Fig. 3B) . This was also inconsistent with the results observed for COC-P4 cumulus cells.
Progesterone Regulation of AVEN Protein Expression
Supplementation with a nonmetabolizable progestin (COC-P4/R5020) resulted in higher expression of AVEN in oocytes at 24 h post-IVM, but there was no change in cumulus cell expression (Fig. 4, A and B) . This increase in AVEN expression corresponded to a decline in apoptosis (i.e., a decrease in active caspase 3 expression and an increase in BCL-xL expression in both the oocytes and their cumulus cells (Fig. 4, A and B) .
AVEN Localization
AVEN was localized primarily to the cytoplasm of germinal vesicle (GV)-and metaphase II (MII)-stage oocytes and their surrounding cumulus cells under control conditions (Figs. 5  and 6 ). In contrast, oocytes matured in the absence of cumulus cell P4 synthesis (COC-P4) displayed both cytoplasmic-and chromatin-associated AVEN localization (Figs. 5 and 6), whereas AVEN was diffusely localized to both the cytoplasm and the nucleus of the surrounding cumulus cells (Fig. 5) . Additionally, active caspase 3 appeared to be localized to discrete aggregates of cytoplasmic organelles in COC-P4 oocytes ( Fig. 6 and Table 3 ).
AVEN and BCL-xL Protein Binding in Bovine COCs
Co-immunoprecipitation analysis revealed AVEN binding to BCL-xL in immature bovine GV (0h) and COC control IVM oocytes (24h) and their cumulus cells (Fig. 7A) . However, despite high AVEN expression, the levels of AVEN bound to BCL-xL was markedly decreased in COC-P4 matured (T24h) oocytes and their cumulus cells (Fig. 7B) .
Effect of P4 Synthesis Inhibition on Oocyte Mitochondria
Oocytes matured under control IVM conditions or in the presence of dimethyl sulfoxide (vehicle control) were characterized by an even distribution of mitochondria throughout the oocyte cortex and small aggregations of mitochondria in the periphery of the oocyte (Fig. 8) . In contrast, COC-P4 oocytes were characterized by large aggregations of mitochondria in the cytoplasm, resulting in large areas of the cytoplasm void of active mitochondria (Fig. 8) . The fluorescence intensity of the oocytes, a measure of metabolically active, respiring mitochondria, was reduced in oocytes matured in the absence of P4 (Fig. 8D) .
DISCUSSION
The findings of the current study confirm and elaborate our earlier observation that cumulus cell P4 synthesis and PR signaling during oocyte maturation in cattle are essential to O'SHEA ET AL.
FIG. 2. Bovine COCs were matured under control conditions or in the presence of 1 lM trilostane (T). Representative
Western blot analyses are shown of putative biomarkers of oocyte quality at 0, 6, 12, and 24 h of in vitro oocyte maturation in bovine oocytes (A) or in cumulus cells (B). Columns represent average protein content, and error bars represent standard deviations for n ¼ 3, with loading normalized to GAPDH. a,b,c Different superscript letters indicate significant differences (P , 0.05) between groups, whereas identical characters indicate lack of significant differences. a,b,c Different superscript letters indicate significant differences (P , 0.05) between groups, whereas identical characters indicate lack of significant differences.
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FIG. 4.
Bovine COCs were matured in the presence of either R5020 (þR), a synthetic progestin, alone or in conjunction with 1 lM trilostane (T24h þ R5020). Representative Western blots are shown of oocytes (A; 70 oocytes/lane) and cumulus cell (B; 15 mg of protein) samples in order to determine expression levels of AVEN, BCL-xL, and active caspase 3, and GAPDH was used as a loading control. Densitometry was normalized to GAPDH expression; columns represent average protein content, and error bars represent standard deviations for n ¼ 3.
a,b,c Different superscript letters indicate significant differences (P , 0.05) between groups, whereas identical characters indicate lack of significant differences. T, trilostane treatment.
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oocyte developmental competence [7] . Here we highlighted the importance of PR signaling to the completion of bovine oocyte nuclear and cytoplasmic maturation and identified AVEN as a key downstream mediator of P4 regulation of oocyte survival and protection from apoptosis.
P4, PR Signaling, and Oocyte Meiotic Maturation
In agreement with our earlier findings [7] , we noted a decrease in nuclear and membrane PR expression in oocytes that occurred simultaneously with their increased expression in their surrounding cumulus cells following IVM. It would appear that in line with other reproductive tissues [33] [34] [35] [36] [37] , COC PR expression is autoregulated in a cell-type-specific manner by direct binding of P4 synthesized by the cumulus cells during maturation, as PR expression did not change in COCs whose P4 synthetic activity was inhibited by trilostane during maturation. In addition, specific blocking of COC PGR activity during IVM also suppressed differential regulation of PGR expression without affecting mPR expression. Moreover, we observed a reduction in MAPK phosphorylation in oocytes matured in the absence of cumulus cell P4 synthesis, suggesting a conserved role for P4 regulation of oocyte meiotic maturation across species. Furthermore, our data implies that regulation of nuclear maturation in cattle may be mediated by mPRs and not PGRs, as treatment with the PGR antagonist aglepristone during IVM did not alter pMAPK expression. Our findings concur with earlier work carried out in Xenopus sp., where microinjection of mPRb antibodies into oocytes inhibited P4-induced oocyte maturation [38] . Conversely, O'SHEA ET AL.
FIG. 6.
Representative confocal laser scanning photomicrographs show immunofluorescence detection of AVEN in bovine oocytes. AVEN was visualized in red, active caspase 3 was visualized in green, and DNA was visualized in blue (DAPI stained). A matched rabbit IgG antibody was used as the negative control to establish a pixel intensity that eliminated 99% of the background signal. Background fluorescence was then subtracted by applying this threshold to all images. 0 h, immature oocyte; 24 h (control), in vitro-matured oocyte; 24 h (trilostane), in vitro-matured oocyte in the presence of trilostane. 
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microinjection of mRNA encoding Myc-tagged Xenopus mPRb resulted in an accelerated rate of P4-induced oocyte maturation [38] .
Downstream of P4 Signaling: Dynamic Regulation of AVEN
In the current study, inhibiting cumulus cell P4 synthesis or blocking COC PGR activity during IVM induced increased expression of AVEN in both oocytes and their surrounding cumulus cells in bovine. These findings suggest that AVEN may play a role in P4 regulation of oocyte maturation via the PGRs. P4 is known to induce gene transcription by signaling through PGRs. P4 binding causes conformational changes in the progesterone receptors, which induces receptor dissociation from the inhibitory chaperone complex, thus allowing receptor AVEN (i) or BCL-xL (ii) protein was performed at 0, 24, or T24 h. Western blotting of precipitation with AVEN and BCL-xL antibodies was used to determine AVEN and BCL-xL binding. iii) Input: Western blotting was performed at each time point, using extract that had not undergone the IP procedure, in order to get baseline levels of expression for AVEN and BCL-xL. A total of 100 oocytes or 20 mg of cumulus cell protein was used per time point for all studies. For densitometry, columns represent average protein content, and error bars represent standard deviations for n ¼ 3, with loading normalized to GAPDH. a,b,c Different superscript letters indicate significant differences (P , 0.05) between groups, whereas identical characters indicate lack of significant differences. 0 h, immature oocytes; 24 h, in vitro-matured oocytes; T24 h, in vitro-matured oocytes in the presence of trilostane.
homodimerization and binding to specific P4 response elements within the promoter of target genes [39, 40] . DNAbound receptors subsequently increase or decrease rates of gene transcription. Using in silico analysis of the AVEN promoter region, we previously identified a potential PR binding element consensus sequence (O'Shea et al., unpublished data). Earlier studies have shown that AVEN expression is steroid hormone regulated [16, 18] ; therefore, it is possible that cumulus cell transcription of AVEN is regulated by P4 via the PGRs. However, it is unlikely that this would account for the altered AVEN expression observed in the oocytes, as the breakdown of the oocyte nuclear membrane following resumption of meiosis means that transcriptional activity is limited within the oocyte. A possible explanation might be that P4 signals in oocytes through the PGR receptors in a nongenomic manner during maturation. Rapid nongenomic effects of P4 have been reported in other systems including PGR-induced acceleration of Xenopus oocyte maturation and activation of the Src/Ras/MAPK pathway in breast cancer cells [1, [41] [42] [43] . Nongenomic P4 signaling through the PGRs is not well defined; however, one known mechanism involves the interaction of proteins with the Src homology-3 (SH3) domains present in the N-terminal domains of both PGR-A and PGR-B. Mutation studies in Xenopus oocytes have shown that that the acceleration of GV breakdown caused by overexpression of the classical PGR is dependent on the integrity of the SH3 interaction domain [42] . It has also been shown that the rapid progestin-induced activation of Src and downstream MAPK in breast cancer cells is dependent on PGR-SH3 domain interaction and is not transcriptionally dependent [42] . Alternatively, AVEN may also be regulated downstream of the actual P4 signaling event. Post-translational events such as phosphorylation, glycosylation, and ubiquitination can stabilize a protein or mark it for degradation [44, 45] , which would lead to altered protein expression in an indirect manner. The AVEN protein is known to contain a BCL-xL binding site [21] , multiple ATM phosphorylation sites [20] , and cathepsin D and caspases 8/9 cleavage sites [31, 32] . In addition, the AVEN protein contains several conserved putative phosphomotifs, including an additional CK2 motif, an additional ATM motif, and a PKA motif (Fig. 1) , all of which are known regulators of the cell cycle and/or oocyte maturation and may function during oocyte maturation in cattle. 
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P4 Signaling and Apoptosis
In the current study, we report that inhibition of P4 synthesis by cumulus cells during IVM leads to a reduced expression of the antiapoptotic BCL-xL protein, coupled with increased active caspase 3 expression. Work in Xenopus oocytes has shown that active MAPK signaling in metaphase-arrested Xenopus egg extracts prevents apoptosis in vitro [46] , as phosphorylation of caspase 9 at Thr125 by pMAPK blocks caspase 9 cleavage and subsequent caspase 3 activation [47] . Therefore, P4 regulation of the MAPK signaling pathway, in an PGR-independent manner, may promote not only oocyte maturation but also oocyte survival. Similarly, in the current study, blocking COC PGR activity during IVM also decreased BCL-xL and increased active caspase 3 expression, which implies P4 signaling through the PGRs is involved in preventing apoptosis and promoting cell survival in bovine COCs. Moreover, the addition of R5020 to trilostane-treated IVM medium rescued the COCs from undergoing apoptosis as shown by reduced active caspase 3 expression in R5020-supplemented COCs compared to those matured in the absence of P4. These data implicate P4 specifically in the prevention of apoptosis in COCs during IVM. Our novel findings highlight a central role for P4 as a cell survival signal that inhibits apoptosis within the bovine oocyte during maturation, and removal of this signal leads to reduced oocyte quality and ultimately reduced embryonic survival [7] . We should consider that detection of caspase 3 activation in viable oocytes, albeit of reduced developmental competence, suggests that a threshold level of active caspase 3 expression is required for the activation of the cell death pathway. This theory is supported by data which show that early embryos can tolerate some caspase 3 activation [48] . At the level of the cytoplasm, our study correlates the reduction in embryonic development observed when P4 synthesis is inhibited during the maturation process [7] with altered mitochondrial distribution within the ooplasm. The number of mitochondria is thought to be an indicator of oocyte developmental competence; reduced numbers of mitochondria have been associated with abnormal distribution of cytoplasmic organelles during embryogenesis [49] . Furthermore, studies in both cattle and mice have shown that embryos which contain less ATP in their cytoplasm develop slowly and contain a lower number of cells [50, 51] .
Using an immunopreciptation technique, we showed that AVEN is normally complexed with BCL-xL in bovine COCs matured in the presence of P4. Inhibition of P4 synthesis during IVM resulted in increased AVEN expression and BCL-xL depletion and a decrease in BCL-xL and AVEN interaction, coupled with oocyte apoptosis. These findings suggest that BCL-xL and AVEN act synergistically to prevent apoptosis such that, when Bcl-xL is depleted, the prosurvival activity of AVEN is abolished. A similar interaction was previously reported in breast cancer cells treated with DNA-damaging reagents [25] . Recent analysis of the AVEN protein sequence has identified a BCL2 homology 3 (BH3) domain, indicating that AVEN is a novel member of the BCL2 family of apoptotic regulators [52] . Evidence has shown that when a BH3 domain peptide adopts an a-helical conformation, its affinity for binding antiapoptotic BCL2 proteins, such as BCL-xL, increases [53, 54] . Therefore, we can speculate that P4 regulates the AVEN protein at a structural level so that inhibition of cumulus cell P4 synthesis during IVM disrupts the ability of AVEN to bind to BCL-xL, causing BCL-xL protein instability, leading to protein degradation and activation of apoptosis within the oocyte.
To further understand the mechanism by which P4 regulates AVEN protein in bovine COCs during IVM, immunostaining of oocytes and intact COCs was performed. AVEN was localized in the cytoplasm of GV and MII oocytes and their cumulus cells under normal IVM conditions. However, we observed AVEN localization to both the nucleus and the cytoplasm when cumulus cell P4 synthesis was blocked during IVM. Nuclear accumulation of AVEN in these oocytes may be the result of an inability of CRM1 to bind to the nuclear export sequence (NES) on the AVEN protein. In Xenopus oocytes, removal of this bovine-conserved NES caused enhanced nuclear accumulation of AVEN and inhibited the ability of AVEN to regulate cell cycle progression [55] . Interestingly, nuclear localization of AVEN protein was associated with active caspase 3 expression in 65% of the oocytes imaged in the current study; thus COCs showing reduced caspase 3 expression may be developmentally competent.
AVEN: A Novel Biomarker of Oocyte Quality
AVEN protein expression observed in the oocytes was mirrored in the cumulus cells, thus, providing a novel noninvasive method of tracking a protein whose expression may reflect the developmental competence and status of the oocyte. In this study, we found that by analyzing AVEN protein expression within the cumulus cells, it is possible to ascertain whether the corresponding bovine oocyte has undergone meiotic maturation. This could be potentially useful in oocyte selection for in vitro fertilization.
In conclusion, the present study demonstrates that P4 has an antiapoptotic effect on the cumulus oocyte complex during maturation and that this cell survival mechanism is mediated by the nuclear P4 receptors. We also identified AVEN as a putative biomarker of oocyte quality, whose dynamic regulation by P4 could be determined by molecular analysis of the cumulus cells.
